A Pivotal, Phase IIb/III study of recombinant plasma gelsolin (rhu-pGSN) for Community-Acquired Pneumonia (CAP)
Latest Information Update: 22 Mar 2019
At a glance
- Drugs Gelsolin (Primary)
- Indications Community-acquired pneumonia
- Focus Registrational; Therapeutic Use
Most Recent Events
- 22 Mar 2019 New trial record